Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;9(6):444-54.

A roadmap to key pharmacologic principles in using antipsychotics

No authors listed

A roadmap to key pharmacologic principles in using antipsychotics

No authors listed. Prim Care Companion J Clin Psychiatry. 2007.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Three Variables That Determine Response to Any Druga
Figure 2.
Figure 2.
Narrow Range Between Efficacy and Behavioral Toxicity With D2 Receptor Antagonistsa,b
Figure 3.
Figure 3.
Predicted Change in Distribution Curves for Olanzapine as a Result of Changing Dosea
Figure 4.
Figure 4.
Predicted Change in Distribution Curves for Risperidone as a Result of Changing Dosea

Similar articles

Cited by

References

    1. Weiden PJ, Preskorn SH, and Fahnestock PA. et al. Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap. J Clin Psychiatry. 2007 68suppl 7. 1–48. - PubMed
    1. Preskorn SH, Flockhart DA. 2006 Guide to Psychiatric Drug Interactions. Prim Psychiatry. 2006;13:35–64.
    1. Levy RH, Thummel KE, and Trager WF. et al. Metabolic Drug Interactions. Philadelphia, Pa: Lippincott, Williams & Wilkins. 2000
    1. Preskorn SH. Classification of neuropsychiatric medications by principal mechanism of action: a meaningful way to anticipate pharmacodynamically mediated drug interactions (pt 1) J Psychiatr Pract. 2003;9:376–384. - PubMed
    1. Preskorn SH. Classification of neuropsychiatric medications by principal mechanism of action: a meaningful way to anticipate pharmacodynamically mediated drug interactions (pt 2) J Psychiatr Pract. 2004;10:177–181. - PubMed

LinkOut - more resources